When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ZLAB - Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga
Zai Lab Limited
Gainers
Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform TikTok.
SIGNA Sports United N.V. (NYSE: SSU) gained 41.6% to $1.23.
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) rose 33.2% to $0.2864. Novo Integrated Sciences recently announced it received an Underwriting Clearance Notice for a $70 million coupon.
Cellectar Biosciences, Inc. (NASDAQ: CLRB) jumped 33.8% to $2.4357. Cellectar Biosciences announced up to $103 million private placement financing with certain institutional investors.
Avalon GloboCare Corp. (NASDAQ: ALBT) gained 27% to $1.2250. Avalon GloboCare announced a notice of publication for key U.S. patent filed jointly with the Massachusetts Institute of Technology.
GD Culture Group Limited (NASDAQ: GDC) shares gained 24.9% to $3.460 after the company said AI Catalysis Corp. has launched an interactive livestreaming game on TikTok.
Helius Medical Technologies, Inc. (NASDAQ: HSDT) climbed 24.1% to $9.16 after gaining around 9% on Friday.
Wheels Up Experience Inc. (NYSE: UP) gained 24% to $2.4701.
Canopy Growth Corporation (NASDAQ: CGC) gained 23% to $0.6660.
EpicQuest Education Group International Limited (NASDAQ: EEIQ) gained 21.1% to $1.2959.
Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 19.7% to $0.5444.
Aravive, Inc. (NASDAQ: ARAV) shares climbed 19.2% to $0.1669 after falling 6% on Friday.
Cibus, Inc. (NASDAQ: CBUS) jumped 18.4% to $17.66.
Cabaletta Bio, Inc. (NASDAQ: CABA) surged 15.7% to $15.42. Citigroup initiated coverage on Cabaletta Bio with a Buy rating and announced a price target of $22.
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) gained 15.5% to $12.26. Olema Pharmaceuticals announced a private placement ...